文献速递牙周病

牙周治疗可减轻2型糖尿病患者的全身炎症

Treatment of periodontitis reduces systemic inflammation in type 2 diabetes.
PubMed 文献 · J Clin Periodontol · 2020-05-12

研究纳入83例2型糖尿病成人和75例无糖尿病对照,牙周炎患者接受牙周治疗并随访12个月。结果发现糖尿病合并牙周炎者基线全身炎症高于单纯牙周炎者,牙周治疗后全身炎症下降幅度更大。

要点

  • 糖尿病合并牙周炎者基线全身炎症显著高于无糖尿病牙周炎者。
  • 牙周治疗可显著改善临床指标并降低龈沟液生物标志物。
  • 糖尿病合并牙周炎者牙周治疗后全身炎症下降更明显。

核心结论

  • 糖尿病与牙周炎共同存在时可能增加全身炎症,牙周治疗后可见全身炎症降低。

研究设计与样本

  • 招募2型糖尿病成人83例和无糖尿病对照75例,牙周炎患者接受牙周治疗并随访12个月。
  • 检测龈沟液和血清炎症标志物及血糖控制指标,采用结构方程模型评估牙周治疗对口腔和全身炎症的影响。

主要发现

  • 牙周治疗使临床状态显著改善,并降低龈沟液生物标志物(从基线至第12个月)。
  • 基线时糖尿病合并牙周炎者全身炎症显著高于无糖尿病牙周炎对照(Δ = 0.20,p = .002),两组口腔炎症无显著差异。
  • 牙周治疗后糖尿病合并牙周炎者全身炎症下降幅度大于单纯牙周炎者(Δ = -0.25,p = .01)。

临床怎么用

  • 对2型糖尿病合并牙周炎患者,牙周治疗可能有助于减轻全身炎症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To assess the impact of periodontal treatment on systemic inflammation in type 2 diabetes. MATERIALS AND METHODS: Adults with type 2 diabetes (n = 83) and without diabetes (controls, n = 75) were recruited, and participants with periodontitis received periodontal treatment and 12 months' follow-up. Biomarkers for periodontal inflammation (gingival crevicular fluid interleukin-6, tumour necrosis factor-α, interleukin-1β, interferon-γ, matrix metalloproteinase-8, matrix metalloproteinase-9, adiponectin) and serum markers of inflammation and diabetes control (glycated haemoglobin, high sensitivity C-reactive protein, interleukin-6, tumour necrosis factor-α, interleukin-1β, interferon-γ, leptin, adiponectin) were measured. Structural equation modelling was used to evaluate periodontal treatment effects on oral and systemic inflammation. RESULTS: Periodontal treatment resulted in significant improvements in clinical status and reductions in gingival crevicular fluid biomarkers from baseline to month 12. Structural equation modelling identified that, at baseline, individuals with diabetes and periodontitis had significantly higher systemic inflammation than non-diabetic controls with periodontitis (Δ = 0.20, p = .002), with no significant differences between groups for oral inflammation. There was a greater reduction in systemic inflammation following periodontal treatment in individuals with diabetes and periodontitis compared to those with periodontitis but not diabetes (Δ = -0.25, p = .01). CONCLUSIONS: Diabetes and periodontitis together appear to increase systemic inflammation, with evidence of reductions following periodontal treatment.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Preshaw PM, Taylor JJ, Jaedicke KM, et al. Treatment of periodontitis reduces systemic inflammation in type 2 diabetes. J Clin Periodontol. 2020. PMID: 32106333. doi:10.1111/jcpe.13274

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。